CV Lattes
Universidade de São Paulo (USP). Faculdade de Medicina (FM) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Bachelor's at Medicina from Universidade Federal de Minas Gerais (1988), master's at Ciências Biológicas e Médicas from Université de Paris VII (1996) and doctorate at Medicina e Ciências from Université de Paris VII (2001). Has experience in Medicine, focusing on Hematology, acting on the following subjects: chronic myeloid leukaemia, bone marrow transplant, allogeneic bone marrow transplant, glanzmann's thrombasthenia and cd34 cell dose. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The Nucleus of Cellular Therapy - NuTeC will be founded on the union of the Regional Blood Center of Ribeirão Preto (Hemocentro RP) and Butantan. Hemocentro RP expertise in cellular therapy will be added to Butantan excellence in the development and production of health applied products to develop CAR T cell therapy. The activities to be conducted by NuTeC are aligned with the scope of th…
We propose a program of basic and clinical research to isolate, culture, and characterize embryonic ,somatic, and neoplastic stem cells in order to understand their biology and apply this knowledge to therapy, comprising four research lines: (1) pluripotent stem cells (SC) (embryonic SC and induced pluripotent SC); (2) somatic SC (hematopoietic SC, mesenchymal SC, endothelial SC, and canc…
Recent studies and accomplishments on monogenic diseases have served not only to alleviate the dilemma of patients with these disorders, but also have yielded valuable information on biological processes relevant to other more common conditions. However, few centers are prepared to diagnose, follow up, and investigate monogenic developmental diseases in Brazil, the largest Latin American …
Enabling gene therapy for sickle cell anemia (SCA) will represent a curative treatment for patients with an indication for hematopoietic cell transplantation (HCT) who do not have an HLA-identical donor. The gene therapy is based on the genetic editing of autologous hematopoietic stem cells and hematopoietic progenitors (HSCP). The main strategies used are: the addition of a non-sickle ce…
| 2 / 2 | Ongoing research grants |
| 1 / 1 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 4 / 4 | All research grants and scholarships |
| Associated processes | |